Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trinity Biotech buys Xtrana's Biopool unit:

This article was originally published in Clinica

Executive Summary

Dublin, Ireland-based Trinity Biotech is to buy the assets and goodwill of Xtrana's Biopool haemostasis division for $6.25 million, with an initial $3.6 million paid immediately and the remainder over a 36-month period. Biopool has operations in Ventura, California, and in Umea, Sweden. The acquisition will take Trinity into a segment of the clinical laboratory market where it was not previously present, as well as strengthening its portfolio with over 50 additional products, Trinity says. It will also boost US distribution.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts